Search Results - "Hing, Zachary A"
-
1
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
Published in Cancer discovery (01-04-2018)“…Bromodomain and extra-terminal (BET) family proteins are key regulators of gene expression in cancer. Herein, we utilize BRD4 profiling to identify critical…”
Get more information
Journal Article -
2
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
Published in Nature communications (06-01-2023)“…Richter’s Transformation (RT) is a poorly understood and fatal progression of chronic lymphocytic leukemia (CLL) manifesting histologically as diffuse large…”
Get full text
Journal Article -
3
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
Published in Journal of hematology and oncology (15-01-2021)“…Exportin 1 (XPO1/CRM1) is a key mediator of nuclear export with relevance to multiple cancers, including chronic lymphocytic leukemia (CLL). Whole exome…”
Get full text
Journal Article -
4
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia
Published in Nature communications (03-11-2021)“…Rare, recurrent balanced translocations occur in a variety of cancers but are often not functionally interrogated. Balanced translocations with the…”
Get full text
Journal Article -
5
Characterization of coding synonymous and non-synonymous variants in ADAMTS13 using ex vivo and in silico approaches
Published in PloS one (29-06-2012)“…Synonymous variations, which are defined as codon substitutions that do not change the encoded amino acid, were previously thought to have no effect on the…”
Get full text
Journal Article -
6
Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura
Published in British journal of haematology (01-03-2013)“…Summary Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare, recessively inherited genetic disorder with varying clinical presentation that is…”
Get full text
Journal Article -
7
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia
Published in Blood (14-05-2015)“…Despite the therapeutic efficacy of ibrutinib in chronic lymphocytic leukemia (CLL), complete responses are infrequent, and acquired resistance to Bruton…”
Get full text
Journal Article -
8
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma
Published in Clinical cancer research (15-10-2019)“…Aberrant Myc expression is a major factor in the pathogenesis of aggressive lymphoma, and these lymphomas, while clinically heterogeneous, often are resistant…”
Get full text
Journal Article -
9
Single‐nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF‐cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family
Published in British journal of haematology (01-04-2014)Get full text
Journal Article -
10
Dysregulation of PRMT5 in Chronic Lymphocytic Leukemia Supports Transformation to Diffuse Large B-Cell Lymphoma
Published in Blood (15-11-2022)Get full text
Journal Article -
11
Exploring the Role of the Recurrent Exportin 1 (XPO1/CRM1) Mutations E571G and E571K in Chronic Lymphocytic Leukemia
Published in Blood (02-12-2016)“…Background Exportin 1 (XPO1/CRM1) is a critical component of the nuclear to cytoplasmic export machinery. As such, XPO1 shuttles tumor suppressor proteins…”
Get full text
Journal Article -
12
Abstract 2260: Evaluating a rare t(X;14)(q28;q32) translocation reveals MTCP1 as a driving factor in chronic lymphocytic leukemia
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in Western countries and is spelled by substantial genetic and clinical heterogeneity…”
Get full text
Journal Article -
13
PRMT5 Initiates an Epigenetic Program That Promotes Progression of Chronic Lymphocytic Leukemia
Published in Blood (08-12-2017)“…Background: Epigenetic alterations that occur as a result of arginine methyltransferase activity play a critical role in normal biological functions, and…”
Get full text
Journal Article -
14
CD37 in acute myeloid leukemia: a novel surface target for drug delivery
Published in Blood advances (30-09-2024)“…Acute myeloid leukemia (AML) is the most common and lethal leukemia in adults. AML consists of many genetic subtypes which limits broad applicability of…”
Get full text
Journal Article -
15
The Eµ-Myc/TCL1 Transgenic Mouse As a New Aggressive B-Cell Malignancy Model Suitable for Preclinical Therapeutics Testing
Published in Blood (03-12-2015)“…Background: Aggressive B-cell lymphomas occurring in the setting of Chronic Lymphocytic Leukemia (CLL) as a large cell transformation are an important clinical…”
Get full text
Journal Article -
16
Next generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematologic malignancies
Published in Leukemia (20-05-2016)“…The nuclear export receptor, Exportin 1 (XPO1), mediates transport of growth-regulatory proteins including tumor suppressors and is overactive in many cancers,…”
Get full text
Journal Article -
17
A Novel Inhibitor of BET Family Bromodomains Demonstrates In Vivo and I n Vi tro Potency in B-Cell Malignancies
Published in Blood (03-12-2015)“…▪ Chronic Lymphocytic Leukemia (CLL) is a B-cell malignancy with aberrant activation of the B-cell receptor (BCR) pathway. Despite durable remissions with…”
Get full text
Journal Article -
18
Next Generation XPO1 Inhibitor Shows Improved Efficacy and In Vivo Tolerability in Hematologic Malignancies
Published in Blood (03-12-2015)“…▪ Restoring nuclear localization of tumor suppressors by blocking exportin 1 (XPO1) holds promise as a new therapeutic paradigm in many cancers, including…”
Get full text
Journal Article -
19
Single-Nucleotide Variations Defining Previously Unreported ADAMTS13 Haplotypes Are Associated With Differential Expression and Activity Of The VWF-Cleaving Protease In a Salvadoran Congenital Thrombotic Thrombocytopenic Purpura Family
Published in Blood (15-11-2013)“…Although autosomal recessive hematologic disorders are individually rare and difficult to ascertain, studies involving one or more homozygous affected children…”
Get full text
Journal Article -
20
Single-nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF-cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family
Published in British journal of haematology (01-04-2014)Get full text
Report